FAIRFIELD, N.J.--(BUSINESS WIRE)--Aug. 10, 2006--Unigene Laboratories, Inc. (OTCBB: UGNE) announced its financial results for June 30, 2006. Revenue for the three months ended June 30, 2006 was...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Aug. 8, 2006--Unigene Laboratories, Inc. (OTCBB: UGNE) will release financial results for the quarter ended June 30, 2006, at approximately 7:30 AM EDT on...
FAIRFIELD, N.J.--(BUSINESS WIRE)--July 25, 2006--Unigene Laboratories, Inc. (OTCBB: UGNE) and Upsher-Smith Laboratories, Inc. have jointly filed in the U.S. District Court for the Southern District...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Nov. 17, 2005--Unigene Laboratories, Inc. (OTCBB: UGNE) will host a conference call on Tuesday, November 22, 2005 at 9:00 AM EST to discuss its third quarter...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Nov. 2, 2005--Unigene Laboratories, Inc.'s (OTCBB: UGNE) President and CEO, Dr. Warren Levy, will speak at the Rodman and Renshaw Techvest 7th Annual Healthcare...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Oct. 20, 2005--Unigene Laboratories, Inc.'s (OTCBB: UGNE) President and CEO, Dr. Warren Levy, will speak at the PIPEs Conference 2005 on Wednesday, October 26th at...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Oct. 18, 2005--Unigene Laboratories, Inc.'s (OTCBB: UGNE) President and CEO, Dr. Warren Levy, will speak at the C.E. Unterberg, Towbin Emerging Growth Life...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Sept. 26, 2005--Unigene Laboratories, Inc.'s (OTCBB: UGNE) President and CEO, Dr. Warren Levy, will speak at the 7th Annual UBS Warburg Global Life Sciences...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Sept. 19, 2005--Unigene Laboratories, Inc. (OTCBB:UGNE) and Yale University have executed agreements to enable Unigene to acquire exclusive rights to their...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Sept. 14, 2005--Unigene Laboratories, Inc. (OTCBB:UGNE) has received a $4 million milestone payment from Upsher-Smith Laboratories, Inc. for receiving FDA approval...
FAIRFIELD, N.J.--(BUSINESS WIRE)--Sept. 8, 2005--Unigene Laboratories, Inc.'s (OTCBB: UGNE) President and CEO, Dr. Warren Levy, will speak at the 3rd Annual ThinkEquity Partners Conference on...
#7: UGNE News Unigene and Novartis Complete Technology Transfer For Calcitonin Manufacturing; Sandoz Successfully Concludes First Full-Scale Production Campaign
FAIRFIELD, N.J.--(BUSINESS WIRE)--Aug. 22, 2005--The transfer of Unigene Laboratories, Inc. (OTCBB: UGNE) proprietary manufacturing technology to Novartis for manufacturing calcitonin has been...
MINNEAPOLIS--(BUSINESS WIRE)--Aug. 16, 2005--Upsher-Smith Laboratories, Inc. announces the launch of new Fortical(R) calcitonin- salmon (rDNA origin) Nasal Spray, an effective treatment option for...
#5: UGNE News FDA Approves Fortical, Unigene's Nasal Calcitonin Product for Postmenopausal Osteoporosis; Unigene to Receive $4 Million Milestone Payment from Upsher-Smith
FAIRFIELD, N.J.--(BUSINESS WIRE)--Aug. 15, 2005--Unigene Laboratories, Inc. (OTCBB:UGNE) has received approval from the U.S. Food and Drug Administration ("FDA") for Fortical(R) calcitonin-salmon...